Status:
NOT_YET_RECRUITING
Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy
Lead Sponsor:
Assiut University
Conditions:
Diabetic Nephropathy
Eligibility:
All Genders
18-80 years
Brief Summary
Diabetic kidney disease (DKD) is one of the most common microvascular complications of type 2 diabetes mellitus (T2DM), affecting up to 40% of diabetic patients and accounting for the leading cause of...
Eligibility Criteria
Inclusion
- Adult aged 18-80 years, both genders.
- clear history of T2DM
Exclusion
- Kidney disease caused by any other causes
- Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 - m2
- Existing obvious infection
- Acute stage of cardiovascular or cerebrovascular diseases
- Acute complications of diabetes recently (such as diabetic ketoacidosis, et al.)
- Associated malignant tumors
- Hematological system, and autoimmune system diseases
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07173686
Start Date
October 1 2025
End Date
November 1 2026
Last Update
September 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.